Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,630 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04665544 | Tracers for Endometrial Cancer Sentinel Node Labeling(TESLA-1) | unknown | N/A | 83 | University Medical Centre MariborOTHER | 3 | Jun 14, 2021 | clinicaltrials |
| NCT04905030 | Education, Immigration and HPV Vaccination: an Informational Randomized Trial | unknown | N/A | 2,500 | Karolinska InstitutetOTHER | 1 | Jun 11, 2021 | clinicaltrials |
| NCT01611766 | Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)? | unknown | Phase 3 | 356 | Shanghai Gynecologic Oncology GroupOTHER_GOV | 1 | Jun 10, 2021 | clinicaltrials |
| NCT04918628 | Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer(CRTCP) | unknown | Phase 2 | 50 | Taizhou HospitalOTHER | 1 | Jun 9, 2021 | clinicaltrials |
| NCT03709316 | A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer | unknown | Phase 3 | 384 | Zai Lab (Shanghai) Co., Ltd.INDUSTRY | 1 | Jun 2, 2021 | clinicaltrials |
| NCT04063072 | ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.(ERAS-Gyneco) | unknown | N/A | 1,800 | Ospedale Regina Montis RegalisOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT04911114 | Targeted Physical Activity to Improve Mobility and Falls Risk in Women Living With Ovarian Cancer(BE-BALANCED) | unknown | N/A | 30 | University of British ColumbiaOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT04836663 | A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors | unknown | Phase 2 | 90 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04556669 | Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors | unknown | Phase 1 | 30 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | May 27, 2021 | clinicaltrials |
| NCT04395612 | Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer(CQGOG0101) | unknown | Phase 2 | 38 | Chongqing University Cancer HospitalOTHER | 1 | May 21, 2021 | clinicaltrials |
| NCT03676959 | A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Recurrent or Metastatic Cervical Cancer | unknown | Phase 1 | 101 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | May 13, 2021 | clinicaltrials |
| NCT04884906 | Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer | unknown | Phase 2 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 13, 2021 | clinicaltrials |
| NCT04556539 | Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer | unknown | Phase 2 | 104 | Jiangxi Qingfeng Pharmaceutical Co. Ltd.INDUSTRY | 1 | May 12, 2021 | clinicaltrials |
| NCT04859361 | Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ | unknown | N/A | 104 | University Medical Centre MariborOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT03852823 | Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours | unknown | Phase 1 | 192 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Apr 30, 2021 | clinicaltrials |
| NCT04868097 | Predicting Adjuvant Post-operative Radiation Therapy in Patients With Cervical Cancer Stage IB2 | unknown | N/A | 52 | Kaplan Medical CenterOTHER | 1 | Apr 30, 2021 | clinicaltrials |
| NCT00703105 | Ovarian Dendritic Cell Vaccine Trial | unknown | Phase 2 | 36 | Loyola UniversityOTHER | 1 | Apr 26, 2021 | clinicaltrials |
| NCT04361370 | Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian Cancer(OPEB-01) | unknown | Phase 2 | 44 | Yonsei UniversityOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT04846842 | A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer | unknown | Phase 2 | 46 | Lee's Pharmaceutical LimitedINDUSTRY | 0 | Apr 19, 2021 | clinicaltrials |
| NCT04337632 | Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer | unknown | Phase 3 | 338 | Hunan Cancer HospitalOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04828616 | Study of DP303c Injection in Patients With Advanced Ovarian Cancer | unknown | Phase 2 | 104 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Apr 2, 2021 | clinicaltrials |
| NCT03951415 | Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer(DOMEC) | unknown | Phase 2 | 55 | Leiden University Medical CenterOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04819685 | Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury | unknown | Phase 4 | 520 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT00920920 | An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer(EMBRACE) | unknown | — | 1,416 | Medical University of ViennaOTHER | 1 | Mar 25, 2021 | clinicaltrials |
| NCT04815408 | PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer | unknown | Phase 2 | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 25, 2021 | clinicaltrials |
| NCT04812938 | Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of Ovarian Cancer by Mean of Papanicolau Test(PAPAudit) | unknown | — | 190 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT03000192 | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | unknown | — | 3,000 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04461574 | Orcellex® Brush Versus Cervex-Brush® on Vault Smear Adequacy in Patients Treated With Radiotherapy for Cervical Cancer | unknown | N/A | 160 | Princess Margaret Hospital, Hong KongOTHER_GOV | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04068974 | Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer | unknown | Phase 2 | 28 | Peking Union Medical College HospitalOTHER | 1 | Mar 16, 2021 | clinicaltrials |
| NCT04800978 | Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy | unknown | Phase 2 | 37 | Samsung Medical CenterOTHER | 0 | Mar 16, 2021 | clinicaltrials |
| NCT04789941 | How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix | unknown | Phase 2 | 50 | Assiut UniversityOTHER | 0 | Mar 10, 2021 | clinicaltrials |
| NCT04579861 | GO SOAR1: Post-Operative Morbidity and Mortality Following Gynaecological Oncology Surgery(GO SOAR1) | unknown | — | 1,100 | Faiza GabaOTHER_GOV | 1 | Mar 9, 2021 | clinicaltrials |
| NCT04787159 | Endometrial Cancer International Database(ECID) | unknown | — | 1,000 | Assiut UniversityOTHER | 0 | Mar 9, 2021 | clinicaltrials |
| NCT04783649 | Clinical Validation of Cervical Cancer Screening Methods | unknown | — | 2,500 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT04400942 | Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy | unknown | — | 600 | Ospedale Policlinico San MartinoOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT03808857 | A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive | unknown | Phase 2 | 80 | Genor Biopharma Co., Ltd.INDUSTRY | 1 | Mar 3, 2021 | clinicaltrials |
| NCT04748978 | OPPIuM Technique and Myolysis With Diode Laser Dwls(Myolysis) | unknown | N/A | 35 | University of CagliariOTHER | 1 | Feb 15, 2021 | clinicaltrials |
| NCT03207061 | Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? | unknown | N/A | 500 | Imperial College LondonOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT03543215 | Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? | unknown | — | 500 | Imperial College LondonOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT04251676 | Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis | unknown | — | 200 | National Taiwan University HospitalOTHER | 0 | Feb 11, 2021 | clinicaltrials |
| NCT04747717 | Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer | unknown | N/A | 30 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Feb 11, 2021 | clinicaltrials |
| NCT04714931 | Sentinel Lymph Node Assessment in Ovarian Cancer (TRSGO-SLN-OO5) | unknown | N/A | 200 | Acibadem UniversityOTHER | 1 | Feb 10, 2021 | clinicaltrials |
| NCT02247323 | Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125(CA125) | unknown | — | 200 | Beni-Suef UniversityOTHER | 1 | Feb 2, 2021 | clinicaltrials |
| NCT02822157 | Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer(CLIO) | unknown | Phase 2 | 160 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT04508686 | Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1) | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT04577950 | A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer(SENNAN) | unknown | N/A | 120 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04637022 | 4K Versus 3D Laparoscopic Colporraphy by Surgeons in Training: a Prospective Randomized Trial | unknown | — | 50 | Catholic University of the Sacred HeartOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT04582552 | The Clinical Markers for PARP Inhibitors-related Efficacy in Ovarian Cancer(ROMP) | unknown | — | 60 | Xiaoxiang ChenOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT04711421 | Using Pedometers for the Assessment and Enhancement of Mobility in Gynaecological and Oncological Patients Following Surgery. | unknown | N/A | 150 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jan 15, 2021 | clinicaltrials |
| NCT02624531 | Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009)(SYSUGO-005) | unknown | N/A | 60 | Sun Yat-sen UniversityOTHER | 1 | Jan 7, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Jun 14, 2021source: clinicaltrials